MDGL

Madrigal Pharmaceuticals, Inc.

Healthcare · $11.9B market cap

We can't put a fair value on MDGL right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?

Equity per share growth-0.4% a year✗

Sales growth12.6% a year✓

Free cash flow growth—?

Return on invested capital-53.8%✗

Follow MDGL

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 9, 2026: no open-market purchases and 24 sales worth $6.2M. Why purchases matter

Sales

Sibold William John

President and CEO · 2026-09-11

Sold

$66K

Sibold William John

President and CEO · 2026-09-11

Sold

$415K

Sibold William John

President and CEO · 2026-09-11

Sold

$837K

Sibold William John

President and CEO · 2026-09-11

Sold

$652K

Sibold William John

President and CEO · 2026-09-11

Sold

$199K

Show all 24 sales

Sibold William John

President and CEO · 2026-09-11

Sold

$371K

Sibold William John

President and CEO · 2026-09-11

Sold

$86K

Sibold William John

President and CEO · 2026-09-11

Sold

$117K

Sibold William John

President and CEO · 2026-09-11

Sold

$57K

Sibold William John

President and CEO · 2026-09-11

Sold

$32K

Sibold William John